NCT06087978View on ClinicalTrials.gov

Study of RPT193 in Healthy Adult Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

July 5, 2023

Primary Completion Date

October 12, 2023

Study Completion Date

October 12, 2023

Conditions

Healthy Male Subjects

Interventions

DRUG

14C RPT193

Radiolabelled RPT193

Trial Locations (1)

68502

Celerion, Lincoln

All Listed Sponsors

lead

RAPT Therapeutics, Inc.

INDUSTRY